Low-molecular-weight impurity in poloxamer 188 responsible for atypical cell culture performance for mAb production
Abstract
During a recent manufacturing campaign for a monoclonal antibody using a fed-batch process, poor cell culture performance was observed across two manufacturing sites with similar scales and equipment. Root cause analysis indicated that the poor cell culture performance was linked to the production basal media. Genealogy of the precursor raw materials used in the media revealed that a particular lot of Poloxamer 188 (P188) was the common link to the poor-performing media lots. P188 serves a critical role in protecting cells against shear in cell culture bioprocesses. However, the small-scale studies suggested that the poor cell culture performance was cytostatic in nature rather than being caused due to lack of shear protection. Several P188 lots were tested analytically using SEC-MS and RP-LC-MS methods and a unique low molecular weight species was identified in the suspect lot of poloxamer. The impurity was identified to be polypropylene oxide (PPO), a reaction intermediate in P188 synthesis. Spiking studies with PPO further confirmed its cytostatic nature. This case study highlights yet another scenario where lot-to-lot variability continues to impact bioprocesses and re-emphasizes the need for robust analytical and cell-culture raw material screening methods.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Impurities in the surfactant Poloxamer 188 have been shown to induce cytostatic effects and atypical cell culture performance during monoclonal antibody production.
“For instance, impurities in the surfactant Poloxamer 188 have been shown to induce cytostatic effects and atypical cell culture performance during monoclonal antibody production (Bandyopadhyay et al., 2022), while inter-laboratory studies in cell-free systems demonstrate that reagent preparation and site-specific factors can substantially influence experimental variability (Cole et al., 2019).”
From Challenges and solutions in transitioning to animal-free standards: a comprehensive analysis of components in human cell-based developmental neurotoxicity assays (2026) · cites this paper as Bandyopadhyay et al., 2022
Cites
Impacts of intentional mycoplasma contamination on CHO cell bioreactor cultures
Fratz‐Berilla, E. J., Faison, T., Kohnhorst, C. L., Velugula‐Yellela, S. R., Powers, D. N., Brorson, K., & Agarabi, C. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27161 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Spänle, J. V., Haiber, L. M., & Seeger, B. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1800157 · Cited by 1 · see citing works
- Authors
- Bandyopadhyay, A., Kosanam, H., Yang, R.-S., Gupta, B., Naralakattu, N., Pakhale, S., Kress, J., Richardson, D., & Ly, J.
- Venue
- Journal of Biotechnology
- Publisher
- Elsevier BV
- Published
- 2022-06
- Volume
- 351
- Pages
- 13-22
- ISSN
- 0168-1656
- Cited by
- 7
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review